<p class="abstract"><strong>Background:</strong> The parotid gland and the other salivary glands provide a crucial role in the oral cavity by secreting saliva that makes eating, swallowing, speaking, and digesting easier. In order to explore the prevalence of parotid gland tumours by age and gender, clinical modes of presentation, surgical treatments, histological pattern of parotid gland tumours, assess treatment success, and assess consequences, a prospective clinicopathological research was conducted.</p><p class="abstract"><strong>Methods:</strong> The study was conducted among patients who presented in the outpatient department of ear, nose and throat (ENT) and head and neck surgery (HNS), Government Medical College (GMC), Srinagar with lesions of the salivary glands. The present study was an observational study conducted over a period of 18 months w.e.f. May 2020 up to October 2021. </p><p class="abstract"><strong>Results:</strong> A total of 220 subjects were enrolled in the present study. More than half of patients were males. The participants were (33.89±15.7) years old on an average. Males predominated over females among the recruited individuals (59% versus 41%). Sub-mandibular gland lesions were most common in the patients (50.4%), followed by parotid gland lesions (38.6%), minor salivary gland lesions (6%) and sub-lingual gland lesions (5%). Pleomorphic adenoma was the most prevalent neoplastic lesion (29.4%). The most prevalent non-neoplastic lesion was parotitis (21.1%).</p><p class="abstract"><strong>Conclusions:</strong> More often than malignant tumours, benign parotid tumours are more common. Malignant parotid tumours usually present at a later clinical stage and begin to develop at a younger age than other tumour types. Accurate clinical diagnosis, with the use of fine needle aspiration cytology (FNAC) and imaging as needed, is essential for effective therapy. The primary therapeutic option is a safe operation called a parotidectomy.</p>